Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03393195 · ClinicalTrials.gov registry record · NA
Study of Time-restricted Eating on Weight Loss.
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT03393195 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 137 participants.
The verdict
NCT03393195, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
This is a randomized controlled trial studying the effects of time-restricted eating (TRE) on weight loss in obese humans. Obesity is the number one risk factor for type 2 Diabetes Mellitus (T2DM), and numerous studies demonstrate that weight loss is an effective strategy to prevent T2DM and improve the metabolic health of people diagnosed with T2DM. Unfortunately, classical calorie restriction diets often fail to produce long-term weight loss due to low compliance, reduced resting metabolic rate (RMR), and other factors. Therefore, novel dieting techniques must be explored in order to successfully treat obesity and prevent T2DM. Studies in mice provide compelling evidence that feeding/fasting cycles can be altered to produce beneficial effects on weight loss and metabolic health markers in the absence of calorie restriction. Limited research in human subjects suggests that this feeding paradigm may translate to human health as well, however, more research needs to be done in order to confirm this hypothesis. This study will determine if TRE can lead to weight loss in obese human subjects. Secondary outcomes include changes in body composition, HOMA-IR, hormonal and biochemical serum markers, RMR, and total energy expenditure (TEE).
Interventions
- BEHAVIORAL Time-restricted Eating plan
- BEHAVIORAL Consistent Meal timing plan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2018-07-30 |
| Est. Completion | 2020-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03393195
The ClinicalTrials.gov registry entry for NCT03393195 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Time-restricted Eating plan is the first listed.
NCT03393195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03393195 about?
NCT03393195 is a clinical study titled "Study of Time-restricted Eating on Weight Loss.". This is a randomized controlled trial studying the effects of time-restricted eating (TRE) on weight loss in obese humans. Obesity is the number one risk factor for type 2 Diabetes Mellitus (T2DM), and numerous studies demonstrate that weight loss is an effective strategy to prevent T2DM and improve...
What is the current status of trial NCT03393195?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2018-07-30. Estimated completion is 2020-01-10.
What interventions are being tested in trial NCT03393195?
The interventions under investigation include: Time-restricted Eating plan (BEHAVIORAL), Consistent Meal timing plan (BEHAVIORAL).
Who is sponsoring clinical trial NCT03393195?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.